Search Results

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Comparing outcomes of ILD patients managed in specialised versus non-specialised centres by Marijic, Pavo (Author) , Schwarzkopf, Larissa (Author) , Maier, Werner Albert (Author) , Trudzinski, Franziska (Author) , Kreuter, Michael (Author) , Schwettmann, Lars (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study by Marijic, Pavo (Author) , Schwarzkopf, Larissa (Author) , Schwettmann, Lars (Author) , Ruhnke, Thomas (Author) , Trudzinski, Franziska (Author) , Kreuter, Michael (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Randomisierte kontrollierte Studien und Real-World-Evidence in der Marktzulassung und Überwachung von Hochrisikoprodukten: das Beispiel Paclitaxel by Behrendt, Christian-Alexander (Author) , Rother, Ulrich (Author) , Rümenapf, Gerhard (Author) , Uhl, Christian (Author) , Görtz, Hartmut (Author) , Böckler, Dittmar (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products: the example of paclitaxel by Behrendt, Christian-Alexander (Author) , Rother, Ulrich (Author) , Rümenapf, Gerhard (Author) , Uhl, Christian (Author) , Görtz, Hartmut (Author) , Böckler, Dittmar (Author) ,


    Get full text
    Article (Journal) Online Resource